336 related articles for article (PubMed ID: 1465912)
1. Chronic rejection of renal allografts with four immunosuppressive regimens.
Isoniemi H; Ahonen J; Krogerus L; Eklund B; Höckerstedt K; Salmela K; Häyry P
Transplant Proc; 1992 Dec; 24(6):2716-7. PubMed ID: 1465912
[No Abstract] [Full Text] [Related]
2. Elective cyclosporine withdrawal in renal transplant recipients maintained on triple therapy.
Keitel E; Bittar AE; Losekann A; Deboni L; Ceretta F; Goldani JC; Garcia VD
Transplant Proc; 1992 Dec; 24(6):2606-8. PubMed ID: 1465881
[No Abstract] [Full Text] [Related]
3. Prolonged renal allograft survival in chronic rejection by conversion to triple therapy.
Beckingham IJ; Dennis MJ; Innes A; Burden RP; Morgan AG; Bishop MC
Transplant Proc; 1993 Apr; 25(2):2100. PubMed ID: 8470283
[No Abstract] [Full Text] [Related]
4. Influence of treatment with cyclosporine, azathioprine and steroids on chronic allograft failure. The Collaborative Transplant Study.
Opelz G
Kidney Int Suppl; 1995 Dec; 52():S89-92. PubMed ID: 8587292
[TBL] [Abstract][Full Text] [Related]
5. Late onset acute rejection of renal allografts, an indicator of suboptimum cyclosporin dosage.
Sumethkul V; Jirasiritham S; Chiewsilp P
Transplant Proc; 1996 Jun; 28(3):1461-2. PubMed ID: 8658741
[No Abstract] [Full Text] [Related]
6. Acute rejection under triple immunosuppressive therapy does not increase the risk of late first cadaveric renal allograft loss.
Isoniemi H; Kyllönen L; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Ahonen J
Transplant Proc; 1995 Feb; 27(1):875-7. PubMed ID: 7879216
[No Abstract] [Full Text] [Related]
7. Is sensitivity to cyclosporine influenced by the HLA-DR phenotype of kidney graft recipients?
Kyriakopoulos G; Antoniadis A; Gakis D; Papanikolaou V
Transplant Proc; 1996 Dec; 28(6):3294-5. PubMed ID: 8962278
[No Abstract] [Full Text] [Related]
8. Six-year experience with a triple drug protocol in renal transplantation: analysis of risk factors.
Pallardó LM; Sánchez P; Sánchez J; García J; Orero E; Beneyto I; Cruz JM
Transplant Proc; 1992 Dec; 24(6):2714-5. PubMed ID: 1465911
[No Abstract] [Full Text] [Related]
9. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation.
Reissi D; Bardideh A; Samadzadeh B; Razi A
Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875
[No Abstract] [Full Text] [Related]
10. Treatment of acute renal transplant rejection with FK 506 in patients on cyclosporine after failure of standard antirejection therapy.
Scott-Douglas N; Zimmerman D; Klassen J
Transplant Proc; 1996 Dec; 28(6):3165. PubMed ID: 8962226
[No Abstract] [Full Text] [Related]
11. Azathioprine can be safely stopped in triple drug induction protocols including cyclosporine and steroids in renal transplantation.
Pallardó LM; Sánchez J; Sánchez P; García J; Orero E; Beneyto I; Ros F
Transplant Proc; 1992 Dec; 24(6):2604-5. PubMed ID: 1465880
[No Abstract] [Full Text] [Related]
12. Chagas disease and transplantation.
Vazquez MC; Sabbatiello R; Schiavelli R; Maiolo E; Jacob N; Pattin M; Rearte A
Transplant Proc; 1996 Dec; 28(6):3301-3. PubMed ID: 8962281
[No Abstract] [Full Text] [Related]
13. Current advantage of FK 506 in cadaveric kidney transplantation.
Ciancio G; Rosen A; Loreto-Grand B; Burke G; Siquijor A; Luque C; Esquenazi V; Miller J
Transplant Proc; 1996 Apr; 28(2):1000-1. PubMed ID: 8623207
[No Abstract] [Full Text] [Related]
14. Application of corbrin capsule in human renal transplantation.
Min Z; Oi J; Zhu Y; Wei W
Transplant Proc; 1996 Jun; 28(3):1626-8. PubMed ID: 8658813
[No Abstract] [Full Text] [Related]
15. [Late prognosis of kidney transplantation in children].
Schärer K; Dreikorn K; Mehls O; Müller-Wiefel DE; Horsch R; Gretz N; Brittinger W
Z Kinderchir; 1985 Oct; 40(5):260-2. PubMed ID: 3907190
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin in a porcine renal transplant model.
Almond PS; Moss A; Nakhleh R; Melin M; Chen S; Salazar A; Shirabe K; Matas A
Transplant Proc; 1993 Feb; 25(1 Pt 1):716. PubMed ID: 8438452
[No Abstract] [Full Text] [Related]
17. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
Woodle ES; Thistlethwaite JR; Haas M; Josephson MA; Newell KA; Bruce DS; Millis JM; Piper JB; Charette JI
Transplant Proc; 1996 Apr; 28(2):998-9. PubMed ID: 8623495
[No Abstract] [Full Text] [Related]
18. The clinical relevance of pretransplant recipient immunoresponsiveness in renal transplantation: impact on rejection.
Renna Molajoni E; Cinti P; Evangelista B; Poli L; Cocciolo P; Berloco P; Cortesini R
Transplant Proc; 1996 Feb; 28(1):402-3. PubMed ID: 8644290
[No Abstract] [Full Text] [Related]
19. Results with histological diagnosis in kidney transplant rejections treated with 15-deoxyspergualin.
Kyo M; Ichikawa Y; Hanafusa T; Fukunishi T; Nagano S; Takahara S; Kokado Y; Okuyama A; Ihara H; Ito K; Sagawa S; Sonoda T; Akiyama T; Kurita T; Suzuki S; Amemiya H
Transplant Proc; 1996 Apr; 28(2):910-1. PubMed ID: 8623457
[No Abstract] [Full Text] [Related]
20. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG
Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
[No Abstract] [Full Text] [Related]
[Next] [New Search]
